KRAS and lung adenocarcinoma: Briefly, sequencing data were collected from a lung adenocarcinoma genetically engineered mouse model (GEMM) in which embryonic stem cells were engineered with an evolving CRISPR-Cas9 dynamic lineage tracing system and inducible Kras and Trp53 mutations, henceforth referred to as KP.